期刊文献+

恶性血液病患者肺部感染的致病菌及耐药性分析 被引量:1

下载PDF
导出
摘要 目的分析恶性血液病患者肺部感染的致病菌菌种及其耐药性。方法对在我院住院治疗的恶性血液病且发生肺部感染的186例患者的临床资料进行回顾性分析。结果恶性血液病患者肺部感染186例占同期恶性血液病患者医院内感染的47.57%,共分离出致病菌132株,其中革兰氏阴性菌77株(58.33%),真菌36株(27.27%),革兰氏阳性菌19株(14.39%);按检出率高低,检出的病原菌依次为大肠埃希菌、白色念珠菌、铜绿假单胞菌、金黄色葡萄球菌、肺炎克雷伯杆菌;检出的细菌和真菌均出现不同程度的耐药,部分耐药率达50%以上。结论恶性血液病患者肺部感染的致病菌以革兰氏阴性菌最常见,检出的致病菌均出现不同程度的耐药,应常规做细菌和真菌培养和药物敏感试验以便选择敏感的抗生素进行治疗。
作者 苏珊珊
出处 《内科》 2013年第3期281-282,共2页 Internal Medicine
  • 相关文献

参考文献5

二级参考文献18

  • 1李智山,邓三季.老年患者下呼吸道医院感染病原菌分布及体外耐药监测[J].中华医院感染学杂志,2004,14(4):458-460. 被引量:30
  • 2王学文,应江山,钱晓萍.第三代头孢菌素治疗血液系统恶性疾患继发重症感染的临床分析[J].实用内科杂志,1993,13(3):183-185. 被引量:7
  • 3血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J].中华内科杂志,2007,46(7):607-610. 被引量:249
  • 4Lyman G H, Kuderer N M, Djulbegovic B. Rophylactic ranulocyte colony stimulating factor in patients receiving doseintensire cancer chemotherapy: a metaanalysis[J]. Am J Med, 2002, 113: 766.
  • 5Conti G, Costa R, Antonelli M: Non invasive ventilation in immunocompro- mised patients[ J ]. Minerva Anestesiol, 2011,77 (3) : 342.
  • 6Campo M, Lewis RE, Kontoyiannis DP: Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998- 2009 [J]. J Infect 2010,60(5) : 331.
  • 7Luong ML, Filion C, Labbe AC,, et al: Clinical utility and prognostic val- ue of bronchoalveolar lavage galactomarman in patients with hematologic malignancies[J]. Diagn Microbiol Infect Dis,2010,68(2) : 132.
  • 8Lehmbecher T, Frank C, Engels K, et al:Trends in the postmortem epi- demiology of invasive fungal infections at a university hospital [ J ]. J Infect,2010,61 (3) :259.
  • 9Ito JI, Kriengkauykiat J, Dadwal SS, et al:Approaches to the early treat- ment of invasive fungal infection [ J ]. Leuk Lymphoma 2010, 51 ( 9 ) : 1623.
  • 10张之南.血液病诊断及疗效标准[M]科学出版社,1998.

共引文献2185

同被引文献16

  • 1中华医学会重症医学分会.呼吸机相关性肺炎预防、诊断和治疗指南[J].中华内科杂志,2013,52(6):1-20.
  • 2Flowers CR,Seidenfeld J,Bow EJ,et al. Antimicrobial prophylaxis and outpatient management of fever and neu- tropenia in adults treated for malignancy:American Soci- ety of Clinical Oncology clinical practice guideline[J]. J Clin Oneol, 2013,31 (6) : 794-810.
  • 3Chen YH,Lu PL,Huang CH,et al. Trends in the susceptibility of clinically important resistant bacteria to tigecycline:results from the tigecycline in vitro surveillance in Taiwan study,2006 to 2010 [J]. Antimicrob Agents Chemother,2012,56(3) : 1452-1457.
  • 4Bucaneve G,Micozzi A,Picardi M,et al. Results of a muhi- center, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia[J]. J Clin Oncol, 2014,32(14) : 1463-1471.
  • 5Song JH,Asian Hospital Acquired Pneumonia Working Group. Treatment recommendations of hospital-acquired pneumonia in Asian countries:first consensus report by the Asian HAP Working Group[J]. Am J Infect Control, 2008,36(4 Suppl) : s83-s92.
  • 6Kanj SS,Kanafani ZA. Current concepts in antimicrobial therapy against resistant gram-negative organisms:ex- tended-spectrum beta-lactamase-producing Enterobacteri- aceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa [I]. Mayo Clin Proc, 2011,86 (3) : 250-259.
  • 7Chemaly RF,Hanmod SS,Jiang Y,et al. Tigecycline use in cancer patients with serious infections:a report on 110 cases from a single institution[J]. Medicine (Baltimore), 2009,88(4) : 211-220.
  • 8周文静,马筱玲,高朋,常文娇,周馨,张翠萍.恶性血液病患者感染病原菌分布及耐药性分析[J].中国感染与化疗杂志,2011,11(4):291-294. 被引量:17
  • 9郝建萍,王蕾,朱震宏,哈力达·亚森.血液科医院感染部位及病原菌分析[J].中华医院感染学杂志,2012,22(19):4208-4209. 被引量:13
  • 10陈宏斌,赵春江,王辉,曹彬,徐修礼,褚云卓,胡志东,卓超,胡必杰,刘文恩,廖康,张嵘,曾吉,王勇,罗燕萍,王占伟,刘颖梅,陈潇,田彬,苏丹红,周春妹,邹明祥,郭鹏豪,周宏伟,金炎.2011年中国13家教学医院院内感染常见病原菌耐药性分析[J].中华内科杂志,2013,52(3):203-212. 被引量:86

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部